Huili Wang, Ph.D.

Huili Wang, Ph.D.

Post-doctoral Fellow, Environmental Pathology Training Program
Department of Pathology
University of North Carolina at Chapel Hill
Chapel Hill, NC 27599-7525

huiliw@email.unc.edu

EDUCATION

• Ph.D., Department of Pathology, Duke University
• M.S., Institute of Genetics, Chinese Academy of Sciences, Beijing, China
• B.S., Biology, Henan Normal University, China

PROFESSIONAL EXPERIENCE

• Postdoctoral Research Associate. University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine. Study the function of fucosyltrasferase –IV and -VII in the atherosclerosis lesion development and thrombosis.
• Scientist. Alnis Biosciences, Inc. Development of superparamagnetic iron oxide (USPIO)-cored polymer hydrogel nanoparticles, which are decorated with fluorophor and cell specific targeting molecules, intended for in vivo imaging and targeted cancer chemotherapeutic drug delivery.
• Postdoctoral Research Associate. Duke University Department of Medicine. Characterized the intracellular pathways and gene expression profile induced by the PlA2 polymorphism of platelet integrin GPIIIa, which is a risk factor for both thromboembolic vascular disease and several cancers. Studied the function of caspase-activated DNAase (CAD/ICAD) in the maintaining genetic stability and preventing tumorigenesis.
• Graduate Research. Duke University Department of Pathology. Characterized the intracellular pathways and gene expression profile induced by the PlA2 polymorphism of platelet integrin GPIIIa, which is a risk factor for both thromboembolic vascular disease and several cancers. Studied the function of caspase-activated DNAase (CAD/ICAD) in the maintaining genetic stability and preventing tumorigenesis.

AWARDS

• Postdoctoral Fellowship Support, Environmental Pathology Training Program, Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill.